Steigerwald Gordon Koch Inc Activity Analysis: Key Purchases and Sales in Q3 2026

Steigerwald, Gordon & Koch Inc., a significant investor analyzed through Insider Set, reported notable changes in its portfolio holdings for the period ending June 30, 2026. The disclosed activity includes both substantial additions and reductions across various sectors.

Purchasing Activity: Steigerwald Gordon Koch Inc. demonstrated significant buying interest during this quarter. Notable purchases include a large increase in Cadence Design Systems (CDNS), which saw its share count rise by 109.7%, indicating strong confidence or strategic allocation towards the Technology sector, specifically semiconductor design tools.

Additionally, there were significant buys in Goldman Sachs (GS), where shares increased by a substantial 200.78%. This suggests potential interest in the Financial Services sector, particularly investment banking.

Other sectors showing buying activity include:

• Healthcare: Acquisition of positions like Pfizer (PFE), which increased by 1.2%, and additions to smaller holdings such as Revvity (RVTY) (+1.14%) and Zoetis (ZTS), despite the latter being a significant sell overall.
• Communication Services: Acquisition of positions like Walt Disney (DIS) (+0.81%) and additions to smaller holdings such as Omnicom Group (OMC) (+0.95%).
• Industrials: Acquisition of positions like Check Point Software Technologies (CHKP) (+1.5%) and additions to smaller holdings such as Revvity.
• Basic Materials: Acquisition of a position in Dow Inc. (DOW), albeit with only 0.04% portfolio allocation.

Selling Activity: The investor also showed significant selling activity, particularly in certain sectors and specific stocks. Steigerwald Gordon Koch Inc exited several positions entirely or drastically reduced them based on the disclosed data.

The most prominent sales occurred within Financial Services, including complete exits from holdings of T Rowe Price Group (TROW) and Goldman Sachs, although GS was also a significant buy. Additionally, Zoetis (ZTS) experienced an 80% reduction in its stake.

Sales were noted across other sectors as well:

• Healthcare: Significant reductions or exits from holdings of General Mills (GIS), despite it being in the Consumer Defensive sector, and substantial decreases in Zoetis (ZTS) (-53.49%) and Pfizer (PFE) (-3.07%).
• Consumer Defensive: A major sale was recorded for General Mills (GIS), which saw its share count plummet by 66.12%, effectively exiting or significantly reducing this position.
• Technology: Besides the large buy in Cadence Design Systems, there were significant reductions in Adobe (ADBE) (-72.69%) and Dick's Sporting Goods (DKS) (-1.59%).
• Industrials: Significant reductions in Dow Inc. (DOW) (-61.39%) and United Parcel Service (UPS) (-19.18%).
• Communication Services: A notable reduction in the stake of Walt Disney (DIS) was observed.

In summary, Steigerwald Gordon Koch Inc's portfolio changes for Q2 2026 reflect a dynamic approach to investing. The investor simultaneously increased exposure in key Technology and Healthcare names like Cadence Design Systems (CDNS) and Pfizer (PFE), while reducing stakes significantly in other areas such as Financial Services (TROW, GS) and Consumer Defensive (GIS). These changes provide insights into the investor's current focus and market views for this period.